Evidence map›Paper›PMID 37063752›Full record

ArticleResearch and practice in thrombosis and haemostasis2023

Neutrophils in lung cancer patients: Activation potential and neutrophil extracellular trap formation.

Lisa-Marie Mauracher, Lena Hell, Florian Moik, Moritz Krall, Cornelia Englisch, Johanna Roiß, Ella Grilz, Thomas M Hofbauer, Christine Brostjan, Sylvia Knapp and 2 more

Open access · goldAbstract read
In one paragraph

Article in Research and practice in thrombosis and haemostasis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Lisa-Marie MauracherDepartment of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University of Vienna, Austria.
Lena HellDepartment of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University of Vienna, Austria.
Florian MoikDepartment of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University of Vienna, Austria.
Moritz KrallDepartment of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University of Vienna, Austria.
Cornelia EnglischDepartment of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University of Vienna, Austria.
Johanna RoißDepartment of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University of Vienna, Austria.
Ella GrilzDepartment of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University of Vienna, Austria.
Thomas M HofbauerDepartment of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Austria.
Christine BrostjanDepartment of General Surgery, Division of Vascular Surgery, Medical University of Vienna, Austria.
Sylvia KnappDepartment of Medicine I, Laboratory of Infection Biology, Medical University of Vienna, Austria.
Cihan AyDepartment of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University of Vienna, Austria.
Ingrid PabingerDepartment of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University of Vienna, Austria.
Medical University of Vienna · ATMedical University of Graz · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Patients with cancer have an increased risk of developing venous thromboembolism. Neutrophils and neutrophil extracellular traps (NETs) reportedly influence the risk of cancer-associated thrombosis. Subpopulations of high and low-density neutrophils (HDN/LDN) are of specific interest, as they might have different functions in cancer patients. Objectives: We aimed to investigate differences between HDNs and LDNs of patients with lung cancer and healthy controls, and their ability of activation and NET formation. Methods: Within the framework of the Vienna Cancer and Thrombosis Study, a prospective observational cohort study, HDNs and LDNs from 20 patients with lung cancer and 20 controls were isolated by density gradient centrifugation. The ability of neutrophil subpopulations for activation and NET formation was investigated by flow cytometry. Results: Compared to controls, patients with cancer had higher numbers of total leukocytes, HDNs, and LDNs. LDNs of patients were more frequently in an activated state (CD62L↓/CD16↑) at baseline (median [IQR] 5.9% [3.4-8.8] vs 2.5% [1.6-6.7]). HDNs and LDNs from patients showed a significantly increased response to stimulation with ionomycin (CD11b HDN: 98.5 [95.4-99.4] vs 41.7 [13.4-91.6]; LDN: 82.9 [63-94] vs 39.6 [17.3-72.1]). In addition, HDNs from patients showed a higher capability of NET formation after ionomycin stimulation compared to HDNs from healthy controls (18509.5 [12242.5-29470.3] vs 10001 [6618.8-18384.3]). Conclusion: Protumorigenic LDNs were elevated, and neutrophil subpopulations showed an increased activation profile and ability for NET formation in patients with cancer. These mechanisms might be involved in tumor promotion and contribute to the prothrombotic phenotype of neutrophils in cancer.

Indexed as

cancer-associated thrombosishigh-density neutrophillow-density neutrophillung cancerneutrophil extracellular traps

Identifiers

PMID37063752
PMCPMC10099311
OpenAlexW4324340217

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.